Development of the Integrated Computer Simulation Model of the Intracellular, Transmembrane, and Extracellular Domain of Platelet Integrin α<sub>IIb</sub>β<sub>3</sub> (Platelet Membrane Glycoprotein: GPIIb–IIIa)

Development of the Integrated Computer Simulation Model of the Intracellular, Transmembrane, and Extracellular Domain of Platelet Integrin α<sub>IIb</sub>β<sub>3</sub> (Platelet Membrane Glycoprotein: GPIIb–IIIa)

Bibliographic Details
Main Authors:	Masamitsu Nakayama, Shinichi Goto, Shinya Goto
Format:	Article
Language:	English
Published:	Georg Thieme Verlag KG 2024-01-01
Series:	TH Open
Subjects:	platelet integrin αIIbβ3 molecular dynamic simulation GPIIb/IIIa
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/a-2247-9438

Similar Items

Arteriosclerosis and the promise of GPIIb/IIIa inhibitors in stroke Arteriosclerosis y nuevas perspectivas de los inhibidores del receptor GPIIb/IIIa en stroke
by: GUSTAVO SAPOSNIK, et al.
Published: (2000-03-01)

Dual‐modality imaging for identifying thrombosis via platelet GPIIb/IIIa receptor targeted cyclic RGDfK microbubbles
by: Yabin Wang, et al.
Published: (2024-06-01)

Clot Retraction and Its Correlation with the Function of Platelet Integrin α<sub>IIb</sub>β<sub>3</sub>
by: Daniel Gao, et al.
Published: (2023-08-01)

Current and Future Roles of Glycoprotein IIb–IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction
by: Giuseppe De Luca, et al.
Published: (2024-09-01)

Use of glycoprotein IIb/IIIa antagonists to prevent stent thrombosis in morphine-treated patients with ST-elevation myocardial infarction
by: Bastiaan Zwart, et al.
Published: (2020-02-01)

Sushi Domain Containing 2 (SUSD2) inhibits platelet activation and binding to high-grade serous ovarian carcinoma cells
by: Tyson W. Lager, et al.
Published: (2018-11-01)

Diffuse alveolar hemorrhage; An under-diagnosed and rare complication of glycoprotein IIb/IIIa inhibitors
by: Hamidreza Hekmat, et al.
Published: (2022-09-01)

Glycoprotein IIb/IIIa inhibitor use in cardiogenic shock complicating myocardial infarction: The Portuguese Registry of Acute Coronary Syndromes
by: Carolina Saleiro, et al.
Published: (2023-02-01)

Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2020-01-01)

Maximum likelihood approach suggests positive selection in platelet integrin αIIbβ3 in mammalian species
by: Luís Bernardo Pina-Cabral, et al.
Published: (2019-05-01)

Transmembrane thiol isomerase TMX1 counterbalances the effect of ERp46 to inhibit platelet activation and integrin αIIbβ3 function
by: Zhenzhen Zhao, et al.
Published: (2024-07-01)

Aβ<sub>1–40</sub>-Induced Platelet Adhesion Is Ameliorated by Rosmarinic Acid through Inhibition of NADPH Oxidase/PKC-δ/Integrin α<sub>IIb</sub>β<sub>3</sub> Signaling
by: Bo Kyung Lee, et al.
Published: (2021-10-01)

Introduction of direct-acting antiviral agents alters frequencies of anti-GPIIb/IIIa antibody-producing B cells in chronic hepatitis C patients with thrombocytopenia
by: Takashi Satoh, et al.
Published: (2023-12-01)

Synergistic effect of peptide inhibitors derived from the extracellular and intracellular domain of αIIb subunit of integrin αIIbβ3 on platelet activation and aggregation
by: Alexia V. Gkourogianni, et al.
Published: (2018-01-01)

Phospholipid metabolism and effectiveness of a glycoprotein IIb/IIIa receptor blocker tirofiban in patients with acute coronary syndrome without ST segment elevation
by: Sh. I. Makhamatova, et al.
Published: (2009-12-01)

Clathrin-mediated integrin αIIbβ3 trafficking controls platelet spreading
by: Wen Gao, et al.
Published: (2018-08-01)

Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis
by: JongSung Hahn, et al.
Published: (2023-07-01)

Activation‐induced changes in platelet surface receptor expression and the contribution of the large‐platelet subpopulation to activation
by: Masaaki Moroi, et al.
Published: (2020-02-01)

Incidencia de eventos cardiovasculares mayores intrahospitalarios en pacientes sometidos a tromboaspiración mecánica más IIb/IIIa contra solo inhibidores de la glucoproteína IIb/IIIa en infarto agudo al miocardio con elevación del segmento ST
by: Arcenio A. Lendo-López, et al.
Published: (2024-10-01)

Safety and efficacy of IIb/IIIa inhibitors in combination with highly active oral antiplatelet regimens in acute coronary syndromes: A meta-analysis of pivotal trials
by: Vincent Roule, et al.
Published: (2017-02-01)

Growth Differentiation Factor-15 Correlates Inversely with Protease-Activated Receptor-1-Mediated Platelet Reactivity in Patients with Left Ventricular Assist Devices
by: Maximilian Tscharre, et al.
Published: (2022-04-01)

Ex vivo STUDY OF THE ACTION OF INTEGRIN RECEPTORS ANTAGONIST FROM ECHIS MULTISQUAMATIS SNAKE VENOM ON PLATELETS OF PREGNANT WOMEN WITH COMPICATIONS DURING GESTATION
by: O. M. PLATONOV, et al.
Published: (2023-04-01)

Platelet Activation Pathways Controlling Reversible Integrin αIIbβ3 Activation
by: Jinmi Zou, et al.
Published: (2024-04-01)

Revisiting the survival paradox between stage IIB/C and IIIA colon cancer
by: Cheng Yu, et al.
Published: (2024-09-01)

Association of Antiretroviral Therapy with Platelet Function and Systemic Inflammatory Response in People Living with HIV: A Cross-Sectional Study
by: Karolina Akinosoglou, et al.
Published: (2023-04-01)

Structure, signal transduction, activation, and inhibition of integrin αIIbβ3
by: Honglei Xin, et al.
Published: (2023-02-01)

Pharmacological actions of dieckol on modulation of platelet functions and thrombus formation via integrin αIIbβ3 and cAMP signaling
by: Muhammad Irfan, et al.
Published: (2022-03-01)

Use of glycoprotein IIb/IIIa inhibitors in myocardial infarction in the Russian Federation, according to the Russian Registry of Acute Myocardial Infarction REGION-IM
by: N. S. Kostritca, et al.
Published: (2024-07-01)

Identification of three novel pathogenic ITGA2B and one novel pathogenic ITGB3 mutations in patients with hereditary Glanzmann’s thrombasthenia living in Eastern Turkey
by: Kamuran Karaman, et al.
Published: (2021-02-01)

Platelet Function, Platelet Size and Content of Reticulated Platelets: Interactions in Patients Receiving Dual Antiplatelet Therapy
by: Valeria V. Bodrova, et al.
Published: (2024-10-01)

Reconstitution of Functional Integrin αIIbβ3 and Its Activation in Plasma Membrane-Mimetic Lipid Environments
by: Una Janke, et al.
Published: (2021-06-01)

Identification of one novel pathogenic ITGB3 mutation and two known mutations in two Chinese pedigrees with hereditary Glanzmann thrombasthenia
by: Zhengjing Lu, et al.
Published: (2020-04-01)

GPIbα is the driving force of hepatic thrombopoietin generation
by: Danielle Karakas, et al.
Published: (2021-05-01)

The GPIIb-IIIa defect of platelets in Glanzmann thrombasthenia
by: Alan T. Nurden
Published: (2023-04-01)

GPIIB ALLELIC POLYMORPHISM AS A FACTOR ASSOCIATED WITH THE PROBABILITY OF IMMUNE THROMBOCYTOPENIA AND THE SEVERITY OF HEMORRHAGIC SYNDROME
by: I. I. Zotova, et al.
Published: (2018-07-01)

Using flow cytometry to monitor glycoprotein IIb-IIIa activation
by: Andrew L. Frelinger
Published: (2018-10-01)

Prognostic determinants and functional role of PIK3C2G in stage IIb-IIIa lung adenocarcinoma: insights from clinical and molecular analyses
by: Chao Gao, et al.
Published: (2025-01-01)

CD40L Activates Platelet Integrin αIIbβ3 by Binding to the Allosteric Site (Site 2) in a KGD-Independent Manner and HIGM1 Mutations Are Clustered in the Integrin-Binding Sites of CD40L
by: Yoko K. Takada, et al.
Published: (2023-07-01)

Human platelet antigen 1a epitopes are dependent on the cation-regulated conformation of integrin α(IIb)β(3) (GPIIb/IIIa).
by: Allen, D, et al.
Published: (2012)

Human platelet antigen 1a epitopes are dependent on the cation-regulated conformation of integrin α(IIb)β(3) (GPIIb/IIIa).
by: Allen, D, et al.
Published: (2012)